Mazuecos, A, Villanego, F, Alonso, A, Beneyto, I, Crespo, M, Diaz-Corte, C, Franco, A, Gonzalez-Roncero, F, Guirado, L, Jimenez, C, Juega, J, Llorente, S, Paul, J, Rodriguez-Benot, A, Ruiz, JC, Sanchez-Fructuoso, A, Torregrosa, V, Rodrigo, E, Hernandez, D, Lopez, V, Lopez-Oliva, M, Zarraga, S. Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients. NEFROLOGIA. 2023; 43(5)DOI:10.1016/j.nefro.2022.11.001. PMID:37957107. IF:2.000(Q2/5D).

Sevillano, AM, Caravaca-Fontan, F, Garcia-Galan, LC, Fernandez-Juarez, G, Lopez-Revuelta, K, Guzman, DA, Martin-Reyes, G, Quintana, LF, Rodas, LM, de la Nieta, MDS, Rabasco, C, Espinosa, M, Diaz-Encarnacion, M, San Miguel, L, Barrios, C, Rodriguez, E, Garcia, P, Valera, A, Pena, JK, Shabaka, A, Velo, M, Sierra, M, Gonzalez, F, Fernandez-Reyes, MJ, Heras, M, Delgado, P, Gutierrez, E, Moreno, JA, Praga, M. Effect of Immunosuppressive Treatments on Kidney Outcomes After Gross Hematuria-Related Acute Kidney Injury in Older Patients With IgA Nephropathy. Kidney International Reports. 2023; 8(8)DOI:10.1016/j.ekir.2023.05.027. PMID:37547537. IF:5.700(Q1/1D).

Kiryluk, K, Sanchez-Rodriguez, E, Zhou, XJ, Zanoni, F, Liu, LL, Mladkova, N, Khan, A, Marasa, M, Zhang, JY, Balderes, O, Sanna-Cherchi, S, Bomback, AS, Canetta, PA, Appel, GB, Radhakrishnan, J, Trimarchi, H, Sprangers, B, Cattran, DC, Reich, H, Pei, YR, Ravani, P, Galesic, K, Maixnerova, D, Tesar, V, Stengel, B, Metzger, M, Canaud, G, Maillard, N, Berthoux, F, Berthelot, L, Pillebout, E, Monteiro, R, Nelson, R, Wyatt, RJ, Smoyer, W, Mahan, J, Samhar, A, Hidalgo, G, Quiroga, A, Weng, PTC, Sreedharan, R, Selewski, D, Davis, K, Kallash, M, Vasylyeva, TL, Rheault, M, Chishti, A, Ranch, D, Wenderfer, SE, Samsonov, D, Claes, DJ, Akchurin, O, Goumenos, D, Stangou, M, Nagy, J, Kovacs, T, Fiaccadori, E, Amoroso, A, Barlassina, C, Cusi, D, Del Vecchio, L, Battaglia, GG, Bodria, M, Boer, E, Bono, L, Boscutti, G, Caridi, G, Lugani, F, Ghiggeri, G, Coppo, R, Peruzzi, L, Esposito, V, Esposito, C, Feriozzi, S, Polci, R, Frasca, G, Galliani, M, Garozzo, M, Mitrotti, A, Gesualdo, L, Granata, S, Zaza, G, Londrino, F, Magistroni, R, Pisani, I, Magnano, A, Marcantoni, C, Messa, P, Mignani, R, Pani, A, Ponticelli, C, Roccatello, D, Salvadori, M, Salvi, E, Santoro, D, Gembillo, G, Savoldi, S, Spotti, D, Zamboli, P, Izzi, C, Alberici, F, Delbarba, E, Florczak, M, Krata, N, Mucha, K, Paczek, L, Niemczyk, S, Moszczuk, B, Panczyk-Tomaszewska, M, Mizerska-Wasiak, M, Perkowska-Ptasinska, A, Baczkowska, T, Durlik, M, Pawlaczyk, K, Sikora, P, Zaniew, M, Kaminska, D, Krajewska, M, Kuzmiuk-Glembin, I, Heleniak, Z, Bullo-Piontecka, B, Liberek, T, Debska-Slizien, A, Hryszko, T, Materna-Kiryluk, A, Miklaszewska, M, Szczepanska, M, Dyga, K, Machura, E, Siniewicz-Luzenczyk, K, Pawlak-Bratkowska, M, Tkaczyk, M, Runowski, D, Kwella, N, Drozdz, D, Habura, I, Kronenberg, F, Prikhodina, L, van Heel, D, Fontaine, B, Cotsapas, C, Wijmenga, C, Franke, A, Annese, V, Gregersen, PK, Parameswaran, S, Weirauch, M, Kottyan, L, Harley, JB, Suzuki, H, Narita, I, Goto, S, Lee, HJ, Kim, DK, Kim, YS, Park, JH, Cho, BL, Choi, M, Van Wijk, A, Huerta, A, Ars, E, Ballarin, J, Lundberg, S, Vogt, B, Mani, LY, Caliskan, Y, Barratt, J, Abeygunaratne, T, Kalra, PA, Gale, DP, Panzer, U, Rauen, T, Floege, J, Schlosser, P, Ekici, AB, Eckardt, KU, Chen, N, Xie, JY, Lifton, RP, Loos, RJF, Kenny, EE, Ionita-Laza, I, Kottgen, A, Julian, BA, Novak, J, Scolari, F, Zhang, H, Gharavi, AG. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy. NATURE GENETICS. 2023; 55(7)DOI:10.1038/s41588-023-01422-x. PMID:37337107. IF:31.800(Q1/1D).

de Sequera, P, Perez-Garcia, R, Vega, A, Martinez-Vaquera, S, Acosta, JG, Del Valle, KP, Fernandez-Lucas, M, Garcia-Rubiales, MA, Garcia-Herrera, AL, Coll, E, Merida, E, Martinez-Miguel, P, Castano, I, Gil-Casares, B, Garro, J, Maduel, F. Trial design of the MOTheR HDx study: a multicenter, open-label, prospective, randomized study to explore the morbidity and mortality in patients dialyzed with the Theranova HDx in comparison with online hemodiafiltration. Clinical Kidney Journal. 2023; 16(11)DOI:10.1093/ckj/sfad128. PMID:37915938. IF:3.900(Q1/2D).

Stevens, KI, Mallamaci, F, Ortiz, A, Bover, J, Delanaye, P, Torra, R, Cozzolino, M. 'The forgotten sex': gender disparities in kidney disease. Clinical Kidney Journal. 2023; 17(4)DOI:10.1093/ckj/sfad102. PMID:38628911. IF:3.900(Q1/2D).

Garcia-Prieto, A, de la Flor, JC, Coll, E, Iglesias, E, Reque, J, Valga, F. Expanded hemodialysis: what's up, Doc?. Clinical Kidney Journal. 2023; 16(7)DOI:10.1093/ckj/sfad033. PMID:37398691. IF:3.900(Q1/2D).

Doyágüez P.R., Boldoba N.B., Gimena R., Sevillano B.H., Ballcells R.T.. Renal involvement in rare genetic diseases. Medicine (spain). 2023; 13(79)DOI:10.1016/j.med.2023.05.004. PMID:. IF:(Q/D).

Rodríguez Doyágüez P., Furlano M., Ars Criach E., Arce Y., Guirado L., Torra Balcells R.. Correlación de la inactivación del cromosoma X con la presentación clínica de la enfermedad de Fabry a propósito de un caso. NEFROLOGIA. 2023; 43DOI:10.1016/j.nefro.2022.12.001. PMID:. IF:(Q/D).

Jankowska M., JoséSoler M., Stevens K.I., Torra R.. Why do we keep ignoring sex in kidney disease?. Clinical Kidney Journal. 2023; 16(12)DOI:10.1093/ckj/sfad183. PMID:. IF:(Q/D).

De Arizón L.F., Viera E.R., Pilco M., Perera A., De Maeztu G., Nicolau A., Furlano M., Torra R.. Artificial intelligence: a new field of knowledge for nephrologists. Clinical Kidney Journal. 2023; 16(12)DOI:10.1093/ckj/sfad182. PMID:. IF:(Q/D).

Mendoza, M, Garcia-Manau, P, Bonacina, E, Maiz, N. Re: Angiogenic factors alone or in combination with ultrasound Doppler criteria for risk classification among late-onset small fetuses with or without pre-eclampsia. ULTRASOUND IN OBSTETRICS & GYNECOLOGY. 2025; 66(6)DOI:10.1002/uog.70021. PMID:40878378. IF:6.300(Q1/1D).

Ruiz, CE, Vela, L, Nadal, M, González, N, Marcos, R, Hernández, A, Pastor, S, Coll, E. DNA Damage and Bisphenol Levels in Chronic Kidney Disease Patients Undergoing Hemodialysis. Journal Of Xenobiotics. 2025; 15(5)DOI:10.3390/jox15050167. PMID:41149753. IF:(Q/D).

Garcia, CR, Pastor, S, Gali, AR, Benito, S, El Bachouti, J, Garcia, MAH, Piera, EC. Effect of bisphenols on genomic damage in patients with chronic kidney disease on hemodialysis. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.0769. PMID:. IF:5.600(Q1/1D).

Guasch, AD, de Arizón, LF, Saltos, JJA, El Bachouti, J, Canal, C, Cordoba, C, Perez, M, Perich, LG, Molas, CF, Cabanas, NS. Recurrence of focal segmental glomerulosclerosis after kidney transplantation: over 40 years of experience in our centre. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.1885. PMID:. IF:5.600(Q1/1D).

Delgado, AB, Piera, EC, El Bachouti, J, Zules, RG, Perich, LG, Gali, AR, Benito, S, Ruiz, C. Impact of phase angle on mortality in hemodialysis patients. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.076. PMID:. IF:5.600(Q1/1D).

Benito-García, S, Bardaji, B, Arce, Y, Moya, P, Freiria, XB, Marco, H, Perich, LG, Encarnacion, MMD. CD163+macrophages: a prognostic marker in ANCA vasculitis?. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.0218. PMID:. IF:5.600(Q1/1D).

Ramírez, ERV, de Maeztu, G, de Arizón, LF, Teran, MP, Torra, R. Leveraging AI for early detection of chronic kidney and hereditary kidney diseases: a focus on Alport syndrome. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.1061. PMID:. IF:5.600(Q1/1D).

Perich, RA, Perich, LG, Perez, M, Tort, J, Revuelta, I, Manonelles, A, Molas, CF, Moreso, FJ, Crespo, M, Cañas, L, Comas, J, Arcos, E. Is living kidney donation with expanded criteria safe for the donor? long-term follow-up from the Catalan Registry. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.108. PMID:. IF:5.600(Q1/1D).

Perich, RA, Arcos, E, Comas, J, Cabanas, NS, Tort, J, Revuelta, I, Manonelles, A, Crespo, M, Moreso, FJ, Santandreu, AV, Molas, CF, Perich, LG. Increase in the use of expanded criteria living donors to facilitate preemptive kidney transplantation for our patients. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.0870. PMID:. IF:5.600(Q1/1D).

Perich, RA, Arcos, E, Comas, J, de Arizón, LF, Tort, J, Revuelta, I, Manonelles, A, Crespo, M, Moreso, FJ, Santandreu, AV, Molas, CF, Perich, LG. Long-term outcomes of renal transplantation from expanded criteria living donors. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2025; 40DOI:10.1093/ndt/gfaf116.0869. PMID:. IF:5.600(Q1/1D).